| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 139.94B | 132.12B | 113.74B | 46.11B | 66.89B |
| Gross Profit | 7.29B | 5.62B | 1.28B | -28.49B | -14.94B |
| EBITDA | 31.38B | 24.27B | 18.75B | -16.19B | 7.51B |
| Net Income | -1.63B | -4.23B | -8.17B | -37.39B | -13.28B |
Balance Sheet | |||||
| Total Assets | 291.76B | 276.60B | 282.49B | 285.74B | 288.79B |
| Cash, Cash Equivalents and Short-Term Investments | 7.35B | 4.23B | 12.12B | 17.63B | 13.03B |
| Total Debt | 138.13B | 145.18B | 162.39B | 219.93B | 194.79B |
| Total Liabilities | 252.92B | 235.19B | 241.27B | 255.64B | 231.64B |
| Stockholders Equity | 37.76B | 40.53B | 40.71B | 29.08B | 53.62B |
Cash Flow | |||||
| Free Cash Flow | 17.15B | 20.98B | 7.91B | -16.49B | -5.12B |
| Operating Cash Flow | 37.94B | 37.31B | 26.57B | -6.47B | 5.69B |
| Investing Cash Flow | -10.77B | -11.18B | -16.07B | -7.29B | 2.15B |
| Financing Cash Flow | -24.08B | -33.93B | -16.79B | 18.35B | -2.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$69.39B | 7.51 | 19.38% | 5.38% | 8.54% | 16.57% | |
64 Neutral | HK$54.48B | 8.23 | 11.82% | 4.39% | 1.58% | -16.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$36.12B | 5.82 | 6.37% | 11.39% | -8.09% | 1.87% | |
47 Neutral | HK$105.69B | 113.91 | -6.44% | ― | 1.42% | 3.33% | |
44 Neutral | HK$101.44B | -43.52 | -7.13% | ― | 4.61% | 38.36% | |
43 Neutral | HK$121.23B | -60.78 | -4.06% | ― | 4.08% | ― |